Spark Biomedical
Houston
About Spark Biomedical
Spark Biomedical develops and provides bioelectric medicine solutions using Transcutaneous Auricular Neurostimulation technology. The company's FDA-cleared product, Sparrow Ascent, is a wearable neurostimulation solution for opioid withdrawal designed to address critical needs where existing treatments may fall short. Spark Biomedical is also evolving its technology platform to develop new treatments in areas including neurological health, hemostasis, pediatrics, and women's health. This technology serves as an adjunct or alternative to traditional treatments when medication reduction or balancing the autonomic nervous system is necessary for symptom relief.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.1M
- Funding stage: Early Stage Venture
- Last round: Grant (Oct 2025)
- Website: sparkbiomedical.com
- Phone: +1 844-654-7775
Industries & Categories
Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/spark-biomedical-88246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.